BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2017
View Archived Issues
Daiichi Sankyo announces pipeline highlights of second quarter of fiscal 2017
Read More
Arvinas selects clinical candidate for metastatic castration-resistant prostate cancer
Read More
Astellas profiles pipeline progress of second quarter of fiscal 2017
Read More
FPT-155: a novel therapeutic CD80-Fc fusion protein with potent antitumor activity in vivo
Read More
Clinical evaluation of 177Lu-PP-F11N underway in medullary thyroid cancer
Read More
FDA clears IND for GALGT2 gene therapy program for DMD
Read More
Jazz Pharmaceuticals submits MAA for Vyxeos as treatment of high-risk AML
Read More
Ionis Pharmaceuticals submits MAA to the EMA for inotersen
Read More
Alios BioPharma moves potent and selective TLR7 agonist AL-034 into the clinic
Read More
Sanofi describes novel glucagon receptor ligands for diabetes drug development
Read More
Boehringer Ingelheim patents OX1 receptor antagonists
Read More
Pfizer reflects on achievements of third quarter 2017
Read More
Ono Pharmaceutical divulges novel voltage-gated channel activators
Read More
AstraZeneca identifies ERalpha antagonists and SERDs
Read More
McGill University discloses ARK-1 and PKC-alpha inhibitors
Read More
KRICT presents NAE1 and SAE inhibitors for cancer
Read More
Novartis submits MAA for tisagenlecleucel for B-cell ALL and DLBCL
Read More
Biohaven initiates bioequivalence study of BHV-0223 ODT formulation of riluzole
Read More
Procalcitonin levels have prognostic significance in patients with acute liver failure
Read More
Moderna Therapeutics, AstraZeneca to develop AZD-7970 for heart failure
Read More
ADCendo signs license agreement to support development of cancer drugs
Read More
Inovio Pharmaceuticals begins phase Ib/IIa immuno-oncology trial in glioblastoma
Read More
iPharma and Boehringer Ingelheim enter license agreement for BI-853520
Read More
FDA approves oral Vimpat for partial-onset seizures in pediatric patients
Read More
Bayer seeks E.U. approval of rivaroxaban for patients with coronary or peripheral artery disease
Read More
FDA lifts clinical hold on phase Ib trial of PTX-200 in ovarian cancer
Read More